Download the entire issue - American Association for Clinical ...

2 0 11 N E w P r o d U c T s r E v I E w special section
Advertisement
Exchanges may also occur on the fly. The
cobas c 702 module is a member of the
cobas 8000 modular analyzer series and may
be combined with mid-volume chemistry
(cobas c 502 module) and immunoassay
(cobas e 602 module) modules to create an
integrated platform with 24 unique system
configurations that meets the individual
needs of high-volume laboratories.
Roche Diagnostics
www.mylabonline.com
Booth No. 2205
cobas® e 602 Module
The cobas e 602 module is an immunoassay
module offering up to 170 tests/hour/module
and an initial menu of more than 50
assays. This module uses Roche’s patented
electrochemiluminescence (ECL) technology,
which offers broad measuring ranges and
low-end sensitivity (HCG+β: 0.10– 10,000
mIU/mL). The cobas e 602 module is a
member of the cobas 8000 modular analyzer
series and may be combined with two clinical
chemistry modules to create an integrated
platform with 24 unique system configurations
to meet individual needs of high-volume
laboratories. Combine the cobas 3 602
module with mid-volume chemistry (cobas
c 502 module) and immunoassay (cobas e
602 module) modules to create an integrated
platform with 24 unique system configurations
that meets the individual needs of
high-volume laboratories.
Roche Diagnostics
www.mylabonline.com
Booth No. 2205
9-Minute STAT Cardiac Assays
9-Minute STAT assays for troponin T,
troponin I, NT-proBNP, CK-MB, and
myoglobin from Roche Diagnostics provide
significant turnaround-time improvement
on the cobas® 8000 modular analyzer series.
On average, these STAT assays can produce
the same critical results in half the time with
only one, simple blood draw obtained via the
sophisticated Roche OneTUBE® solution—a
faster, more efficient way to deliver accurate
results without sacrificing performance, precision,
or sensitivity. Laboratories can run a
comprehensive battery of cardiac STAT tests
to provide accurate results faster than current
testing methods.
Roche Diagnostics
www.mylabonline.com
Booth No. 2205
Elecsys Anti-HAV Total Assay
The Roche Elecsys Anti-HAV Total Assay is
an electrochemiluminescence (ECL) immunoassay
for in vitro qualitative detection of
total antibodies (IgM and IgG) to hepatitis A
virus in human serum and plasma. The
assay is intended as an aid in the laboratory
diagnosis of past or acute/recent hepatitis A
infection. The Roche Anti-HAV Total assay
runs on the Elecsys 2010 system, MODU-
LAR ANALYTICS E170 module, cobas e 601
analyzer, cobas e 602 analyzer, and cobas e
411 analyzer.
Roche Diagnostics
www.mylabonline.com
Booth No. 2205
Elecsys Thyroglobulin (Tg) Assay*
The Roche Elecsys Tg Assay is an electrochemiluminescence
(ECL) immunoassay for
quantitative determination of thyroglobulin
in human serum and plasma. Tg levels aid
in monitoring for the presence of local and
metastatic thyroid tissue in patients who
have had thyroid ablation, either with or
without ablative radioiodine therapy. The
Roche Tg assay runs on the Elecsys 2010
system, MODULAR ANALYTICS E170
module, cobas e 601 analyzer, cobas e 602
analyzer, and cobas e 411 analyzer. *Pending
FDA clearance. Available for sale outside the
U.S.
Roche Diagnostics
www.mylabonline.com
Booth No. 2205
Elecsys Human Growth Hormone (hGH) Assay
The Roche Elecsys Human Growth Hormone
Assay is an electrochemiluminescence
(ECL) immunoassay for quantitative determination
of the biologically active 20-kDa
and 22-kDa isoforms of human growth
hormone in serum and plasma. The onestep,
sandwich assay takes only 18 minutes
and demonstrates excellent total precision of
1.7–2.5 CV% for the MODULAR ANALYT-
ICS E170 module, cobas e 601 analyzer, and
cobas e 602 analyzer. The high precision and
reliability of the assay provide a solid base for
a growth hormone assessment. The Roche
Human Growth Hormone assay is available
for all Roche immunoassay systems.
Roche Diagnostics
www.mylabonline.com
Booth No. 2205
Middleware Solutions—Moving Averages
Roche Middleware Solutions offers Moving
Averages, software that monitors the performance
of assays and analyzers in between
QC runs. The laboratory creates automated
protocols within middleware to monitor the
average of patient results on an assay-byassay
basis and between multiple analyzers. If
the average of patient results drifts above or
below pre-defined threshold levels, moving
averages will automatically stop autoverification
and hold test results. The lab will
CliniCal laboratory news July 2011 29